Search
for

    Glossary Allopurinol

    medication that reduces uric acid production to treat gout

    Allopurinol is a medication primarily used to treat gout and certain types of kidney stones by reducing the production of uric acid in the body. It works by inhibiting an enzyme called xanthine oxidase, which is involved in the synthesis of uric acid, thereby preventing the formation of painful urate crystals in joints and tissues.

    Sort by

    Research 30 of 143

    1. Granulomatous Microscopic Colitis Due to Allopurinol The American Journal of Gastroenterology · 2015
    2. Long-term follow-up of a case of feline leishmaniosis treated with a combination of allopurinol and meglumine antimoniate. PubMed · 2023 · 3 citations
    3. TOXIC EPIDERMAL NECROLYSIS International Journal of Dermatology · 1992 · 48 citations
    4. Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore Pharmacology Research & Perspectives · 2019 · 13 citations
    5. Chronic tophaceous gout secondary to self-induced vomiting in anorexia nervosa The Journal of Dermatology · 2010 · 6 citations
    6. The spectrum of nephrocutaneous diseases and associations Journal of The American Academy of Dermatology · 2016 · 5 citations
    7. Cutaneous Reactions to Drugs Elsevier eBooks · 2017 · 3 citations
    8. Gouty Alopecia: An Intriguing Manifestation of Disseminated Tophaceous Gout Journal of Skin and Stem Cell · 2025
    9. ISCHEMIC SKIN FLAPS: WHAT TO USE TO SAVE THEM? A NARRATIVE REVIEW Foco · 2023
    10. Rheumatoid arthritis and gouty arthritis in an adult patient with Down's syndrome 2020
    11. Six-year Retrospective Review of Drug Reaction with Eosinophilia and Systemic Symptoms Acta dermato-venereologica · 2012 · 39 citations
    12. Screening of Tyrosinase, Xanthine Oxidase, and α-Glucosidase Inhibitors from Polygoni Cuspidati Rhizoma et Radix by Ultrafiltration and HPLC Analysis Molecules · 2023 · 12 citations
    13. Extensive scleredema adultorum with loss of eccrine glands Journal of the American Academy of Dermatology · 2014 · 2 citations
    14. Abstract ED05-04: Presurgical models to effectively screen preventive agents Cancer Prevention Research · 2010
    15. HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Elsevier eBooks · 2014 · 2 citations
    16. Questions and answers for clinical insights Journal of Pediatric Health Care · 1995
    17. Drug-induced changes in hair growth Drugs & Therapy Perspectives · 1994
    18. Drug-Induced Skin, Nail and Hair Disorders Drug Safety · 2007 · 114 citations
    19. Fatal Toxic Epidermal Necrolysis Associated with Minoxidil Pharmacotherapy · 2009 · 11 citations
    20. Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis JAAD Case Reports · 2020 · 3 citations
    21. Viviscal: An answer for hair loss in women? Pharmacy Today · 2013
    22. The successful treatment of nephrogenic fibrosing dermopathy (NFD) with mycophenolate mofetil (MMF) Journal of The American Academy of Dermatology · 2005
    23. The prevalence of itch and pain and its characteristics in patients with mild to moderate insufficiency and its relationship to the degree of venous insufficiency Journal of The American Academy of Dermatology · 2005
    24. The use of diphencyprone in dermatology: A retospective audit Journal of The American Academy of Dermatology · 2005
    25. Their year at Parkland Memorial Hospital (2005) Journal of The American Academy of Dermatology · 2005
    26. Use of chemotherapy during human pregnancy Lancet Oncology · 2004 · 724 citations
    27. Mucocutaneous reactions to chemotherapy Journal of The American Academy of Dermatology · 1999 · 275 citations
    28. Severe cutaneous adverse reactions to drugs The Lancet · 2017 · 273 citations
    29. Drug-Induced Hair Loss and Hair Growth Drug Safety · 1994 · 147 citations
    30. Hair Loss in Women The New England Journal of Medicine · 2007 · 129 citations